+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PatientView - Market Research Reports

PatientView is a UK-based research, publishing, and consultancy group, created out of a belief that the views of patients should be considered in all important healthcare decisions (whether a new healthcare product is being developed, or whether a government is instituting changes to a health system). The organisation was formed in response to the emerging powerful new global patient movement.

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups

  • Report
  • June 2024
  • 64 Pages
  • Global
The Corporate Reputation of Pharma in 2023/2024: The Patient Perspective (Global Edition) - The Views of 2,500+ Patient Groups Worldwide - Product Thumbnail Image

The Corporate Reputation of Pharma in 2023/2024: The Patient Perspective (Global Edition) - The Views of 2,500+ Patient Groups Worldwide

  • Report
  • April 2024
  • 138 Pages
  • Global
The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - USA Edition - The Views of 314 USA Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - USA Edition - The Views of 314 USA Patient Groups

  • Report
  • May 2024
  • 50 Pages
  • United States
Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World - Product Thumbnail Image

Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World

  • Report
  • November 2023
  • 63 Pages
  • Global
The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Neurology Edition: The Views of 258 Neurology Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Neurology Edition: The Views of 258 Neurology Patient Groups

  • Report
  • November 2022
  • 54 Pages
  • Global
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Respiratory Edition - The Views of 121 Respiratory Conditions Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Respiratory Edition - The Views of 121 Respiratory Conditions Patient Groups

  • Report
  • October 2022
  • 58 Pages
  • Global
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - HIV/AIDS Edition -The Views of 168 HIV/AIDS Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - HIV/AIDS Edition -The Views of 168 HIV/AIDS Patient Groups

  • Report
  • June 2022
  • 91 Pages
  • Global
The Corporate Reputation of Pharma in 2021- The Patient Perspective - Autoimmune Edition - The Views of 293 Patient Groups (138 of these respondent patient groups specialised in arthritis) - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - Autoimmune Edition - The Views of 293 Patient Groups (138 of these respondent patient groups specialised in arthritis)

  • Report
  • November 2022
  • 57 Pages
  • Global
The Corporate Reputation of Pharma in 2020 - The Patient Perspective - Mental Health Edition: The Views of 80 Mental Health Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2020 - The Patient Perspective - Mental Health Edition: The Views of 80 Mental Health Patient Groups

  • Report
  • November 2021
  • 49 Pages
  • Global
The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups

  • Report
  • October 2022
  • 58 Pages
  • Global
The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Canada Edition - The Views of 100 Canadian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Canada Edition - The Views of 100 Canadian Patient Groups

  • Report
  • May 2024
  • 50 Pages
  • Canada
The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - UK Edition - The Views of 87 UK Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - UK Edition - The Views of 87 UK Patient Groups

  • Report
  • May 2024
  • 59 Pages
  • United Kingdom
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Spain Edition: The Views of 154 Spanish Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Spain Edition: The Views of 154 Spanish Patient Groups

  • Report
  • September 2022
  • 559 Pages
  • Spain
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Italy Edition: The Views of 103 Italian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Italy Edition: The Views of 103 Italian Patient Groups

  • Report
  • September 2022
  • 59 Pages
  • Italy
The Corporate Reputation of Pharma in 2021- The Patient Perspective - France Edition - The Views of 109 French Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - France Edition - The Views of 109 French Patient Groups

  • Report
  • July 2022
  • 60 Pages
  • France
The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups

  • Report
  • August 2022
  • 59 Pages
  • Germany
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups

  • Report
  • August 2022
  • 58 Pages
  • Asia Pacific
  • 17 Results (Page 1 of 1)
Loading Indicator